Expert operational and management solutions for drugs, diagnostic agents, and medical devices development projects.
Vortex Pharma Solution provides in-depth clinical operations expertise covering trial life cycle end-to-end process. Using a holistic system, we ensure that your clinical trial is designed, setup, conducted, and reported with a risk-based approach, reasonable costs and the shortest possible timelines. We offer fit-for-purpose solutions to meet your specific needs and get your trial executed as planned.

Therapeutic areas
- Rare and ultra-rase diseases (orphan drug designation)
- Endocrinology/metabolic diseases (diabetes, obesity, achondroplasia, growth hormone deficiency, hypoparathyroidism, thyroid-related diseases)
- Hepatology (focal liver lesions, non-alcoholic steatohepatitis [NASH])
- Nephrology (chronic kidney disease [CKD])
- Neurology (Alzheimer’s disease)
- Gastroenterology (Crohn’s disease)
- Rheumatology (Osteoarthritis, Rheumatoid Arthritis)
- Haematology (haemophilia, trauma, extensive surgery, intracerebral haemorrhage)
- Cardiovascular (CV outcomes, arterial hypertension)
- Oncology (breast cancer)
- Dermatology (hyperhidrosis)

Trial population
- Paediatrics
- Elderly
- Adults

Phases I to IV, RWE studies, post-authorization safety studies, interventional and observational studies

Vortex Pharma Solution

Org chart

Teams

Offices

Vortex Pharma Solution

Org chart

Teams

Offices

Related companies